TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market ...

The large animal models ... made another improvement: instead of leaving the balloon in until birth, Deprest and his colleagues removed it after six to eight weeks to allow for more normal lung ...

Requests for deidentified participant data should be made to FA or GP. Requests for further analyses ... ≤45% after reperfusion and a symptom-to-balloon time ≥2 and ≤12 hours. The study was ...

With more lung cancer cases being detected via both incidental findings and early screenings, robotic-assisted surgery can make for an all around better experience for patients. Charles Simmons, a ...

forced expiratory volume in one second (FEV1), and diffusion capacity of the lung for carbon monoxide (DLCO). The investigators used these factors to create a prediction model for determining which ...

Mutant RAS, they ... Detecting Evidence of Lung Cancer in Exhaled Breath Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung ...

While medical headlines often focus on the biochemical underpinnings of disease, our body's biomechanics are equally crucial.

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled.

A new lung cancer screening initiative has made significant strides in overcoming barriers to care for low-income, uninsured and minority populations in Central Texas—a critical step toward ...

These common symptoms make it hard for both patients ... Most patients need an average of five sessions. Balloon pulmonary angioplasty may be best for frail and elderly patients with CTEPH. CTEPH is a ...

Lung cancer is the ... facilitated by our powerful model systems, we were able to determine what HDAC3 is doing specifically within the tumor, which allowed us to make the discovery that HDAC3 ...

The Big Pharma is joining forces with researchers from the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center to develop new models for lung diseases like ...